EVALUATING IN VIVO MODELS IN PRECLINICAL DRUG DEVELOPMENT

In vivo models are essential tools during preclinical drug development, enabling researchers to assess the efficacy and safety of novel medications in a living organism. Choosing the appropriate species is crucial to guarantee meaningful preclinical data. This requires a comprehensive understanding of the disease being studied, as well as the drawb